We build Respiro, a connected respiratory platform for inhaled medicine. Smart inhaler sensors and a data platform turn inhaler use and technique into insight. Respiro is built for the people who use those inhalers, and for the pharma, clinicians and partners who build on the data.
Make the medicine, deliver the care, build the technology or study the outcomes: between visits, everyone is working blind. Respiro is built to close that gap.
Doses get missed and mistimed, and no one knows until control slips, or an attack lands someone in hospital.
Most people don't use their inhaler correctly, so much of the dose never reaches the lungs, and the mistake goes unseen.
What happens between appointments is invisible: to patients, to clinicians, and to the brands that made the therapy.
Inhaler sensors, the data platform, and the apps built on it. Take the platform end to end, or work with the layer that fits your programme.
Capture inhaler use and technique, then stream the data to an app: ours or a partner's.
Bring inhaler-use records and technique information together for Respiro apps and partner integrations.
Deliver the insight to patients, clinicians and pharma: through our apps, or your own front end with Respiro underneath.
One platform. Take it whole, or just the engine.
Bring sensors, algorithms and the data platform together with our own apps. Explore the Respiro app for everyday logging, local conditions and a history to share at appointments.
See the full platformAlready have an app or digital therapeutic? Embed the Respiro Connect SDK and pull our APIs: you keep the experience, we're the connected-respiratory engine underneath. Integration by design.
See integration optionsExplore earlier Respiro studies. See the evidence
Different teams can build on the same connected inhaler technology, with an approach shaped around their programme.
Digital companion apps, real-world evidence and drug-device combination products that extend the life and value of an inhaled therapy.
Explore pharma solutionsRemote monitoring built on recorded doses, reliever use and technique: with clinic-ready reports for better-informed respiratory consultations.
Explore clinical solutionsThe Respiro Connect SDK, open APIs and white-label options to embed our connected-inhaler intelligence inside your own digital-health product or device.
Explore integrationTime-stamped inhaler-use and technique data for clinical trials and academic studies, with the measurement plan built around the research question.
Explore collaborationsIn earlier Respiro studies, participant groups that could see their own doses and technique showed better asthma-control scores and lower costs from poorly-controlled disease. Explore the studies, their populations and their findings below.
Figures describe specific study populations, not a promise of individual results. Conference results are labelled as such.
At Respiratory Drug Delivery 2026, a pharmacy-led evaluation in asthma and COPD found nearly three in four patients improved their inhalation technique with Respiro: across three different inhalers.
Read the resultsWith ARTES 4.0 and PNRR backing, we brought CFD simulation and automation to the next generation of inhaler sensors: a project target of reducing the transition from concept to production by 40%.
Read moreA peer-reviewed study tested how accurately RS01X reads each inhalation against a laboratory reference. Across 97 people with asthma, COPD and healthy lungs, agreement was near-perfect.
Read moreTell us a little about your organisation and what you're trying to do. We'll point you to the right part of the platform, and the right person.
We'll only use your details to respond.
Thanks, we'll be in touch shortly.